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A mathematical model is presented which represents the control system 
for erythropoiesis. In the model, it is postulated that the rate of 
erythropoiesis is controlled by a hormone, erythropoietin, which is 
released from the kidney in response to reduced renal oxygen supply. 
Equations are developed which relate erythropoietin release to arterial 
oxyhemoglobin concentration, and hemoglobin production to plasma 
erythropoietin concentration, with appropriate time delays. Effects of 
changes in plasma volume during hypoxia are included. The model is 
used with a digital computer to simulate the dynamic response of the 
erythropoietic system to a step decrease in the po2 of inspired air. The 
response of the model compares favorably with experimental data 
obtained from mice subjected to different degrees of hypoxia. 
1. Introduction 
The total circulating red cell mass in mammals is at least partially 
controlled by a feedback system involving a hormone (erythropoietin) 
which is released from the kidney. It has been shown that this hormonal 
system has the necessary characteristics to provide regulatory control over 
red blood cell production (Erslev, 1960; Jacobson, Gurney & Goldwasser, 
1960). A mathematical model of the complete erythropoietic control system 
should be useful in achieving better understanding of the response of the 
system to different stimuli. A number of models describing the erythropoietic 
system have been proposed. These can be divided into two main groups: 
(i) those dealing with the movement of iron throughout the body as it is trans- 
ferred from one organ to another (Garby, Schneider, Sundquist & Vuille, 
1963; Nooney, 1966; Pollycove & Mortimer, 1961; Sharney, Wasserman, 
Schwartz & Tendler, 1963), and (ii) those describing the behavior of the stem 
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cell population as it applies to the differentiation of cells into the 
erythroid series (Kretchmar, 1966; Lajtha & Oliver, 1960; Newton & Gurney 
1965). In addition, two models have been proposed which include to some 
extent both red blood cell and bone marrow stem cell kinetics (Gall & 
Meno, 1968; Kirk, Orr & Hope, 1968). Most of these models describe only 
parts of the erythropoietic control system and none encompasses the entire 
system with sufficient detail to allow a quantitative appraisal of how the 
different components interact to yield a specific response. 
The model presented herein is a detailed, non-linear representation of the 
control system for erythropoiesis. The model was designed to simulate the 
dynamic response of the erythropoietic system to a step decrease in the 
po2 of inspired air. Respiratory and plasma volume changes are included. 
Although only the response to hypoxia is considered herein, the model can 
also be used to predict the behavior of the system in response to other 
stresses or pathological states. Parameters for the system have been estimated 
for the mouse because of the relative ease of obtaining test data for that 
animal. However, the conclusions derived from model analysis should be 
applicable to other animals. 
2. Description of the System 
The following description is given to provide a basic understanding of the 
system. A more detailed discussion of the various relationships and 
parameters in the model is given in section 3, Parameter Estimation. 
A block diagram showing some of the major components of the erythro- 
poietic control system is given in Fig. I. Erythropoietin is released from the 
kidney in response to an imbalance between available oxygen and tissue 
oxygen requirements (Abbrecht & Malvin, 1966; Jacobson, Goldwasser & 
Gurney, 1959). Erythropoietin acts on the bone marrow to increase the 
production of erythrocytes. The increased number of red blood cells thus 
produced augments the oxygen-carrying capacity of the blood and tends to 
restore adequate oxygenation of renal tissue. 
This control system in itself appears to be relatively simple. However, in 
order to produce a model which can describe the behavior of the system 
under physiological conditions, other factors must be included. Since the 
amount of oxygen carried per unit amount of hemoglobin depends on the state 
of oxygenation of the blood, the lungs must be included as an auxiliary 
system, as well as the relationship between arterial po2 and the percentage 
oxygen saturation of the hemoglobin (the oxyhemoglobin dissociation 
curve). The oxygen-carrying ability of 1 ml of blood is proportional to 
hemoglobin concentration. Therefore, the effects of another independent 
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FIG. 1. Block diagram of a model for the control of erythropoiesis. HbO = oxy- 
hemoglobin concentration, Vi = viscosity factor, HbO = effective oxyhemoglobin 
concentration, R = rate of erythropoietin release, E = plasma erythropoietin con- 
centration, E. = normal plasma erythropoietin concentration, V, = distribution volume 
for erythropoietin, P = rate of hemoglobin production, MT = erythrocyte maturation 
time, L = rate of hemoglobin loss, TH = total circulating hemoglobin, [Hb] = blood 
hemoglobin concentration, Va = blood voiume, VP = plasma volume, VP0 = normal 
plasma volume, Vpr = steady state hypoxic plasma volume, MCV = mean corpuscular 
volume, MCH = mean corpuscular hemoglobin, k = constant. 
control system, that for plasma volume, must also be considered. The total 
amount of hemoglobin present at any given time is the net result of the pro- 
cesses of red cell production and destruction, so that effects of red cell 
survival must also be included. 
In the model, the primary variable monitored by the kidney is considered 
to be blood oxyhemoglobin concentration (the product of hemoglobin 
concentration and percent oxygen saturation). The choice of this variable is 
based on the fact that it is a measure of the oxygen content per unit volume 
of blood and therefore reflects changes in the oxygen input to the kidney 
which occur either as a result of anemia or hypoxic hypoxia. Oxygen input 
to the kidney also depends upon renal blood flow rate. While renal 
autoregulation tends to maintain flow relatively constant, appreciable changes 
may occur as a result of the very high hematocrits and associated changes in 
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blood viscosity which occur after prolonged exposure to severe hypoxia. In 
the model, a multiplicative factor (Vi) operating upon oxyhemoglobin 
concentration is used to represent the effects of viscosity changes on renal 
blood flow and tissue oxygenation. Hereafter, the term oxyhemoglobin 
concentration HbO will refer to the actual concentration HbO multiplied 
by the viscosity correction factor (Vi). 
Renal release of erythropoietin is considered to be inversely related to 
oxyhemoglobin concentration. Plasma erythropoietin concentration then 
depends upon the rates of release by the kidney and of clearance from the 
plasma of the hormone. Erythropoietin causes differentiation of stem cells 
into erythroid cells (Alpen & Cranmore, 1959; Orlic, Gordon & Rhodin, 
1968), and may also regulate the rate of hemoglobin synthesis (Stohlman, 
Ebbe, Morse, Howard & Donovan, 1968). Therefore, the rate of hemoglobin 
synthesis in the model is a function of plasma erythropoietin concentration. 
Because of the time required for erythrocyte maturation, the amount of 
hemoglobin being released into the circulation at any given time depends 
upon the number of precursor cells differentiated into red cells at some 
previous time. This effect is accounted for by the use of a variable time 
delay for erythrocyte maturation. 
The rate of change in total circulating hemoglobin at any given time is 
the difference between the amount being added to the circulation in new 
cells and the amount being lost due to removal of senescent cells from the 
circulation. Hemoglobin concentration is obtained by dividing total hemo- 
globin mass by the sum of erythrocyte volume and plasma volume. 
Erythrocyte volume is calculated from the value of total hemoglobin and the 
red blood cell indices. Plasma volume is incorporated in the model using 
an empirically derived equation. 
3. Parameter Estimation 
Because of the relative ease of obtaining data on the response of the 
mouse’s erythropoietic system to hypoxic stress, data for testing the model 
were obtained from that animal (Mylrea & Abbrecht, 1970). However, in 
estimating values for the various parameters for computer simulation, it 
was necessary to utilize data from several species. 
(A) ERYTHROPOIETIN RELEASE AND PLASMA ERYTHROPOIETIN 
CONCENTRATION 
Because of the low sensitivity of currently available assay methods for 
erythropoietin, it is not usually possible to measure renal arteriovenous 
differences in erythropoietin concentration and renal erythropoietin release 
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(Abbrecht & Malvin, 1966). Thus it was necessary to derive a relationship 
for erythropoietin release from data on plasma erythropoietin concentra- 
tions in hypoxic animals. 
Erythropoietin concentration in the plasma is a function of its rate of 
release by the kidney, rate of clearance from the plasma, and its volume of 
distribution. The half-life of disappearance of erythropoietin from plasma 
has been reported as one to five hours for rats (Keighley, 1962; Reissman, 
Diederich, Ito & Schmaus, 1965; Stohlman & Howard, 1962), and 7.3 hr 
for dogs (Bozzini, 1966). Since smaller animals appear to have a shorter 
plasma erythropoietin half life, a value of approximately two hours was 
estimated for mice and used in the model. A distribution space for 
erythropoietin of approximately two times the plasma volume has been 
reported for the rat (Reissman et al., 1965) and was used in the model. With 
the assumptions that (i) the rate of release of erythropoietin and the distribu- 
tion space are constant during the short time being considered, and (ii) the 
rate of disappearance of erythropoietin from the plasma is proportional 
to the plasma erythropoietin concentration, the following equation can 
be written for plasma erythropoietin concentration : 
J?(t) = 57 (1 -ee-‘iTl)+Eo emtlT1, (1) 
e 
where E(t) = plasma erythropoietin concentration at time t, E, = initial 
plasma erythropoietin concentration, R = rate of erythropoietin release, 
V, = volume of distribution of erythropoietin (taken to be twice plasma 
volume), r, = time constant for erythropoietin disappearance, t = time. 
It is postulated that the rate of erythropoietin release is a function of the 
oxyhemoglobin concentration. A quantitative relationship between these 
two variables was obtained from plasma erythropoietin concentrations 
measured in rats after 8 hr of continuous hypoxic exposure (Reissman et al., 
1965). It was assumed that during the eight-hour exposure period, both 
arterial po2 and the rate of erythropoietin release were constant, and that 
erythropoietin concentration had reached 92% of the steady state value 
(T, = 0.130 days). Distribution space was assumed to be 13.3 ml. (Reissman 
et al., 1965). The rate of erythropoietin release was then calculated from the 
steady state form of equation (1), 
R = I/,E/T,. (2) 
The normal plasma erythropoietin concentration of the rat, which is too low 
to be detectable with the polycythemic mouse assay (Reissman et al., 1965), 
was taken to be approximately one-half the minimum amount detectable 
with the mouse assay. Oxyhemoglobin concentration was determined from 
data obtained in the rat relating percent saturation to altitude (Altland, 
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Brubach, Parker & Highman, 1967). A single exponential equation fits the 
data relating oxyhemoglobin concentration and erythropoietin release 
(Fig. 2). Because of the differences in plasma vohtme and oxyhemoglobin 
El 0 o. ’ ’ ’ ’ ’ s 4 8 12 I6 
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FIG. 2. Relationship between oxyhemoglobin concentration and renal erythropoietin 
release. Points for the rat (&---0) are calculated from data in the literature (see text). 
Erythropoietin release for the mouse (-- ) is one-tenth of the values shown on the 
ordinate. 
dissociation curve between rats and mice (Altman & Dittmer, 1961; Mylrea, 
1968), it was necessary to scale the relationship for the mouse (Fig. 2). The 
resulting relationship between erythropoietin release and oxyhemoglobin 
concentration in the mouse is given by the following equation, 
R(t) = 74.2 e-O.sHbW-T~f, (3) 
where R(t) = rate of erythropoietin release at time t, HbO(t - T2) = oxy- 
hemoglobin concentration at time (t- T2). Recent experimental evidence 
indicates the existence of a renal erythropoietic factor (REF) which by itself 
is not erythropoietically active, but when incubated with serum produces 
erythropoietin (Contrera & Gordon, 1968; Kuratowska, Lewartowski & 
Lipinski, 1964). Some work has been done on the kinetics of the REF- 
erythropoietin system (Zanjani, et al., 1967). From this work there appears 
to be a delay of a few hours between the renal hypoxic stimulus and the 
appearance of erythropoietin in the plasma. Therefore, in the model a delay, 
T2, taken to be equal to four hours, was incorporated between changes in oxy- 
hemoglobin concentration and the associated erythropoietin release. 
(B) HEMOGLOBIN PRODUCTION 
In order to describe the hemoglobin production resulting from a given 
erythropoietin concentration, two distinct questions had to be answered. 
How much hemoglobin was produced at any given time ? When was this 
hemoglobin released into the blood stream? It should be noted that the 
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model predicts the kinetics of hemoglobin production instead of erythrocyte 
production in response to erythropoietin concentration changes. However, 
since the experimental data which were obtained for testing the model show 
little change in mean corpuscular hemoglobin levels during the period of ex- 
posure (Mylrea & Abbrecht, 1970) the kinetics of hemoglobin production 
and erythrocyte production would be similar. 
It was postulated that the rate of hemoglobin production is related to 
plasma erythropoietin concentration by the following equation, 
P(t) = Pm(l-e-klE(‘))+PO, (4) 
where p(t) = rate of hemoglobin production at time t, P,,, = maximum rate 
of hemoglobin production, E(t) = plasma erythropoietin concentration at 
time t, ki = a constant, P, = a basal rate of hemoglobin production. 
The exponential relationship between hemoglobin production and 
erythropoietin concentration was assumed on the basis of data relating the 
increase in total red cell volume to the amount of erythropoietin injected 
daily into rats (Van Dyke & Pollycove, 1962). Equation (4) indicates that 
hemoglobin production rate asymptotically approaches a maximum value 
P, as erythropoietin concentration increases. For an erythrocyte life span of 
20 days, the normal hemoglobin production rate in the mouse would be 
approximately 0.01 g/day (Mylrea & Abbretch, 1970). Maximum hemo- 
globin production in several species has been reported to be five to seven 
times the normal (Crosby & Akeroyd, 1952; Neuberger & Niven, 1951) 
suggesting a value of about O-05 g/day for P,,, in the mouse. The inclusion of 
PO in equation (4) allows some basal hemoglobin production as has been 
suggested by (Nathan, Schupak, Stohlman & Merrill, 1964). The constant 
k, was calculated assuming a basal hemoglobin production of 0.005 g/day 
when erythropoietin concentration is zero. 
In the model, the rate of hemoglobin production determines the amount 
of hemoglobin which will be available for release into the bloodstream at 
some future time. This time delay between the differentiation of the stem cell 
and release of the resulting erythrocytes (the maturation time) may be a 
function of plasma erythropoietin concentration (Stohlman et al., 1968). 
The normal maturation time for erythrocytes is approximately four days 
(Harris, 1963). With an increased stimulus for erythropoiesis, the rate of 
hemoglobin synthesis may be increased and the maturation time cor- 
respondingly shortened (Stohlman et al., 1968). In the model, the maturation 
time for cells undergoing the normal number of divisions is varied from 
2.5 to 4 days, depending upon erythropoietin concentration, with normal 
plasma erythropoietin concentration producing a maturation time of 3.75 
days. 
286 K. C. MYLREA AND P. H. ABBRECHT 
Maturation time = 4 e-0’02gE(t), 0 < E(t) < 16, 
= 2.5, E(t) > 16, (5) 
where E(t) is the erythropoietin concentration at the time of differentiation. 
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FIG. 3. The relationships used in the model for maturation time vs. plasma erythro- 
poietin concentration and for erythropoietin concentration vs. percent of hemoglobin 
released in early cells. -, Maturation time; ------, early maturation. 
With a very strong erythropoietic stimulus, there is evidence that some 
of the erythrocytes skip their terminal division. These cells have a maturation 
time of less than two days (Stohlman et al., 1968; Brecher & Stohlman, 1962). 
They also may have a markedly decreased life span (Brecher & Stohlman, 
1962) which is taken to be equal to six days in the model. The percentage of 
hemoglobin released in these “early” cells is represented in the model by the 
equation : 
Percent released early = 100 (1 --&,/E(I)), (6) 
where E, = erythropoietin concentration below which no early cells are 
produced, E(t) = erythropoietin concentration at the time the stem cells 
were differentiated into the erythroid series. During the calculations, the 
percentage of hemoglobin released in early cells was determined first on the 
basis of plasma erythropoietin concentration. The remainder of the 
hemoglobin was considered to be released in cells which had undergone a 
normal number of mitoses. 
(C) RED BLOOD CELL LIFE SPAN 
In mice exposed to 360 mmHg pressure, the rate of increase of total 
circulating hemoglobin plateaus after 22 days exposure (Mylrea & Abbrecht. 
1970). On the assumption that this change in slope of the total hemoglobin 
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curve was caused by the death of the first group of extra cells produced in 
response to hypoxia, a life span of 20 days was selected. The selection of 20 
days as the normal red blood cell life span does not greatly affect the dynamic 
response of the model except after 20 days exposure when the additional cells 
begin to leave the circulation. To account for the normal variability in cell 
life span (Berlin, 1964), the death of cells produced at any given time was 
distributed in a normal manner about a mean of 20 days, with a one day 
standard deviation. 
(D) BLOOD VOLUME 
Total circulating red blood cell volume was calculated from the total 
circulating hemoglobin and experimentally determined values for mean 
corpuscular hemoglobin (MCH) and mean corpuscular volume (MCV) 
(Mylrea & Abbrecht, 1970). Total blood volume and hematocrit were then 
determined from the values of plasma volume and total red cell volume. 
Mean corpuscular hemoglobin, which changes very little in mice subjected 
to hypoxia (Mylrea & Abbrecht, 1970), is assumed to remain constant in 
the model at a value of 15.9 pg/cell. However, mean corpuscular volume 
increases during the first few days of hypoxic exposure (Mylrea & Abbrecht, 
1970). The model assumes a linear change in MCV from the control value 
to a new steady state value during the first five days of hypoxia. The 
experimentally determined control and steady state values for MCV in 
hypoxic mice (Mylrea & Abbrecht, 1970) were 47.7, 48-8, 50.4 and 52.1 
um3/cell at 740, 510, 440 and 360 mmHg total air pressure, respectively. 
In the model hematocrit was calculated from the relationship 
hematocrit = 1 /[l + (MCH)(V,)/(TH)(MCV)], (7) 
where V, = plasma volume, TH = total circulating hemoglobin. Since 
MCV = Hct/erythrocyte count, the calculated values of hematocrit depend 
upon the average measured steady state values for hematocrit from all 
runs at a given altitude. 
Plasma volume changes were represented by an exponential equation 
fitted to the experimental data (Figs 4 to 6). A steady state value for plasma 
volume was determined for each pressure from the percent decrease found 
in the experimental data (Mylrea & Abbrecht, 1970). The control plasma 
volume was 0,626 ml. Steady state plasma volumes for 510, 440 and 
360 mmHg were 0.600, 0.530 and 0.500 ml, respectively. With the 
representation used, upon exposure to decreased pressure the plasma volume 
decreases from the control value to the new steady state value in an 
exponential manner with a time constant of I.5 days. 
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FIG. 4. Experimental data (Mylrea & Abbrecht, 1970) and the model results for mice 
exposed continuously to a total pressure of 510 mmHg (poz = 106 mmHg). Each point is 
the average of values obtained for nine mice. Different symbols represent different runs. 
The solid lines were obtained by first doing a linear interpolation to obtain daily values for 
the variables for each run, and then averaging the daily values for all runs at that altitude. 
Broken lines show the model output for this altitude, with the exception of the lowest curve, 
which shows the empirically derived relationship used for plasma volume in the model. 






























































































290 K. C. MYLREA AND P. H. ABBRECHT 
- 50 
Total plasma volume 
Time at 360 mmHg (days) 
FIG. 6. Experimental data (Mylrea & Abbrecht, 1970) and the model results for mice 
exposed continuously to a total pressure of 360 mmHg (pO, = 75 mmHg). Each point is 
the average of values obtained for nine mice. Different symbols represent different runs. 
The solid lines were obtained by first doing a linear interpolation to obtain daily values 
for the variables for each run, and then averaging the daily values for all runs at that 
altitude. Broken lines show the model output for this altitude, with the exception of the 
lowest curve, which shows the empirically derived relationship used for plasma volume in 
the model. Experimental values shown for time “0” were obtained on control mice kept 
at atmospheric pressure. 
MODEL FOR CONTROL OF ERYTHROPOIESIS 291 
(E) OXYHEMOGLOBIN CONCENTRATION 
Oxyhemoglobin concentration was calculated in the model by multiplying 
hemoglobin concentration by the percent of hemoglobin saturated with 
oxygen (percent hemoglobin saturation). Hemoglobin concentration was 
determined by dividing total circulating hemoglobin by total blood volume. 
Percent hemoglobin saturation was obtained as described below. 
The amount of oxygen being carried to the erythropoietin producing 
tissues is directly proportional to arterial oxyhemoglobin concentration only 
if blood flow is constant. The high hematocrits which occur during prolonged 
severe hypoxia increase blood viscosity (Crowell & Smith, 1967). This may 
tend to reduce blood flow to the tissues and thereby to decrease tissue 
oxygenation. This effect of viscosity was incorporated in the model via the 
correction factor Vi, obtained from the relationship 
v1 = 1-l -09012 e4’4 Hct 3 (8) 
where Hct = hematocrit = total red cell volume/total blood volume. The 
actual oxyhemoglobin concentration HbO was multiplied by Vi to obtain 
the “effective” oxyhemoglobin concentration HbO. It is recognized that 
the oxygen available to the tissues depends upon the percent extraction as 
well as upon the amount entering in arterial blood. However, percent 
extraction was not included in the model because of inadequate data. 
(F) PERCENT HEMOGLOBIN SATURATION 
The percent of hemoglobin saturated with oxygen (percent hemoglobin 
saturation) was determined from the oxyhemoglobin dissociation curve and 
the value for arterial po,. The oxyhemoglobin dissociation curve for blood 
of the strain of mice used in the hypoxic experiments was determined 
experimentally (Mylrea, 1968). The curve can be described by the following 
equations : 
percent saturation = 100 - 264 e-0’028/po,, 
60 mmHg < arterial pal < 80 mmHg, (9) 
percent saturation = 1.33 poZ - 30, 
30 mmHg < arterial poZ < 60 mmHg. (10) 
No data on alveolar or arterial po2 were available for mice. In man, the 
respiratory response to hypoxia is characterized by an acute decrease in 
arterial poZ which is followed by a gradual rise to a new steady state or 
acclimatized value, that is attained after about three days exposure (Rahn & 
Fenn, 1955). In the model arterial oxygen tensions for different degrees of 
acute exposure were estimated from data obtained on rats (Altland et al., 
1967; Altman & Dittmer, 1961) and are shown as the lower curve in the 
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respiratory system portion of Fig. 1. The assumption that the difference 
between the acute and acclimatized po2 value is the same for mice as 
that reported for humans (Rahn & Fenn, 1955) yields the upper (acclimatized) 
curve for the po,-altitude relationship in Fig. 1. It was postulated that 
arterial poz at a given altitude changed from the acute value to the 
acclimatized value in an exponential manner with a time constant of two 
days. The acute and acclimatized values for arterial par which were used in 
the model are given in Table 1. 
TABLE 1 
Values for acute and acclimatized arterial poZ used in the model 
Total pressure (mmHg) Arterial poz (mmHg) Acute Acclimatized 
510 65 68 
2 56 63 61 7 
The normal arterial poZ for the mouse was taken to be 78 mmHg. 
4. Computer Simulation 
The simulation was performed on a high-speed digital computer (IBM 
7094). From the values of the parameters listed in Table 2, values for each 
of the variables were calculated beginning with percent hemoglobin 
TABLE 2 
Parameter values used in the model 
Normal erythrocyte life span (days) 20 
Erythropoietin threshold, E. (“A” units/ml) 0.100 
Normal plasma erythropoietin concentration (‘A” units/ml) 0.0225 
Normal blood hemoglobin concentration (g/100 ml) 16.8 
Normal total blood volume (ml) I .26 
kI (ml plasma/unit erythropoietin) 5.88 
Tl (days) 0.130 
TZ (days) 0.167 
Ta (days) 1.5 
saturation and continuing around the loop (see Fig. 1). A dynamic simulation 
was obtained by recalculating the values for each of the variables for I-hr 
intervals. Decreasing the length of time between calculated points to less than 
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an hour did not appreciably change the results. Therefore, we believe that the 
digital approximation yields results which would compare favorably with a 
continuous model. 
5. Results and Discussion 
Experimentally determined values for three different air pressures (Mylrea 
& Abbrecht, 1970) are compared with the model predictions (broken curves) 
in Figs 4 to 6. In general, the model simulates the experimental responses 
quite well for all three simulated altitudes. 
The increase in hemoglobin concentration found in man and other animals 
during the first few days of hypoxia is thought to be caused by a hemo- 
concentration and possibly the release of stored red blood cells (Van Liere & 
Stickney, 1963). The model results show clearly that hemoconcentration can 
produce an early increase in hematocrit and hemoglobin concentration 
similar to that found experimentally (Figs 4 to 6). This is particularly evident 
at the lower pressures where there were larger changes in plasma volume. 
The model output for total hemoglobin increased until about 22 days 
exposure, and then dropped slightly at all altitudes. The greatest drop 
occurred at the 360 mmHg pressure, where the experimental data also clearly 
demonstrated a decrease in total hemoglobin beginning at about 22 days. 
At that time there occurs a shift from death of prehypoxic erythrocytes to 
those formed in the early post-hypoxic period, at which time hemoglobin 
production rate is greatest. The loss of the early cells exceeds the nearly steady 
state production rate at 22 days, and results in a net decrease in total 
hemoglobin. The changes in total hemoglobin at 22 days resulted in parallel 
changes in hemoglobin concentration, hematocrit, total red cell volume, and 
blood volume. 
For 360 mmHg there were some significant differences between the hemo- 
globin concentrations predicted by the model and those obtained experi- 
mentally (Fig. 6). The model did not predict as great an increase in hemo- 
globin concentration during the first three days of exposure as was found 
experimentally. This discrepancy may be due to splenic release of erythro- 
cytes, a factor which was not included in the model. The representation for 
plasma volume used in the model (a single exponential) does not produce the 
increase in plasma volume which occurred in the experimental animals on 
the fourth day of exposure to 360 mmHg. Thus the model did not reproduce 
the decrease in measured hemoglobin concentration which occurred at 
that time. 
Early erythrocytes with a shortened life span (6 days) are produced in the 
model during the first four days of hypoxic exposure. However, the 
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amount of hemoglobin released in “early” cells does not constitute a very 
large portion of the initial hemoglobin production. Therefore, it is unlikely 
that short-lived macrocytes of the type found in response to phenylhydrazine- 
induced anemia (Brecher & Stohlman, 1962) were produced in significant 
numbers in mice exposed to even the highest simulated altitude. 
Plasma erythropoietin concentrations during sustained hypoxia have been 
reported for man (Siri et al., 1966), the rat (Stohlman, 1959), and the rabbit 
(Prentice & Mirand, 1961). The results of these studies are difficult to com- 
pare, since different assay methods were used and values were not reported 
in terms of a standard unit. However, the studies all show a similar 
temporal pattern consisting of a prompt rise in plasma erythropoietic 
stimulating activity with the onset of hypoxia, and a return to near baseline 
levels within a few days despite continued hypoxic exposure. 
The pIasma erythropoietin responses predicted by the model for the first 
12 days of hypoxic exposure are shown in Fig. 7. The maximum erythro- 
Time of hypoxm (days) 
FIG. 7. Model predictions for plasma erythropoietin concentration as a function of 
duration of hypoxic exposure for three different pressures. Note the change in scale on the 
abscissa after 12 days. 
poietin concentration predicted by the model at 360 mmHg is of the same 
order of magnitude as the values reported by Reissman et al. (1965) for rats 
exposed to 380 mmHg. In the model plasma erythropoietin concentrations 
at all altitudes reached a maximum after about 12 hours of hypoxia, and then 
decreased rapidly. This behavior is in agreement with the experimental 
results cited above. However. in contrast to the experimental findings, the 
model results do not show a return to near baseline levels after a few days 
of hypoxia. This difference between the model and the experimental results 
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reflects a major deficiency in the understanding of the control of erythro- 
poiesis during prolonged hypoxia. While the initial increase in erythro- 
poiesis appears to be strongly dependent upon an elevation in plasma 
erythropoietin concentration, the increased rate of erythropoiesis during 
prolonged hypoxia occurs in the absence of significantly increased plasma 
erythropoietin concentration. 
These findings imply a change in characteristics of either the controller 
(the kidney) or the plant (the bone marrow) or both of these with time. 
Siri (Siri et al., 1966) has suggested that diminished erythropoietin release 
during prolonged hypoxia might be due to a reduction in “functional” 
hypoxia resulting from adaptive changes in cardiovascular function. 
Improved oxygen delivery to the bone marrow resulting from a rightward 
shift in the oxyhemoglobin curve (Lenfant, Ways, Aucutt & Cruz, 1969) 
might increase the effect of erythropoietin on red blood cell production and 
thus allow increased erythropoiesis to continue without large increases in 
erythropoietin concentration. 
In the model, changes in the effective oxyhemoglobin concentration 
accomplished through the action of the “viscosity” correction result in a 
good representation of the experimentally determined erythropoietic 
response at various altitudes. Simulation without the viscosity correction 
results in substantially lower steady state blood hemoglobin concentrations 
at 360 mmHg than were found experimentally. While the viscosity correction 
allows the model to simulate the overall systems response, it results in 
unrealistically high steady state values for plasma erythropoietin con- 
centration. The viscosity correction may be viewed as an attempt to represent 
the adaptive changes in tissue oxygenation which occur during extended 
hypoxia. However, it is apparent that the use of this correction is an 
oversimplification which does not truly represent the adaptive mechanisms 
which are involved. The complete specification of the time variance in the 
kidney-erythropoietin-marrow relationship must await more precise methods 
of measuring erythropoietin concentration and tissue oxygenation. 
A major use of models such as the one presented herein should be in 
defining the type of information which is required for more complete 
understanding of the system and in planning the experiments to obtain that 
information. At present there are not sufficient physiologic data available 
(nor the means of obtaining it) to allow a quantitative investigation of the 
individual parameters used in the model. However, evaluation of the 
differences and similarities between model output and physiological data from 
mice and other mammals can suggest various types of experiments which 
will provide meaningful insights into the behavior of the individual com- 
ponents and the system as a whole. 
296 K. C. MYLREA AND P. H. ABBRECHT 
This work was supported in part by Grant GB 5874 from the National Science 
Foundation, U.S. Public Health Service Grants AM 10395 and 521 GM 01289 and 
Research Career Development Award 1 K04 GM 19289 from the National 
Institute of General Medical Sciences. 
REFERENCES 
ABBRECHT, P. H. & MALVIN, R. L. (1966). Am. J. Physiol. 210, 237. 
ALPEN, E. L. & CRANMORE, II. (1959). Ann. N. Y. Acad. Sci. 77, 753. 
ALTLAND, P. D., BRUBACH, H. F., PARKER, M. G. & HIGHMAN, B. (1967). Am. J. Physiol. 
212, 142. 
ALTMAN, P. L. & DIMMER, D. S. (Eds.) (1961). Blood and Other Body Fluids, p. 153. 
Washington, D. C., Federation of American Societies for Experimental Biology. 
BERLIN, N. I. (1964). J. Am. med. Ass, 188, 375. 
BOZZINI, C. D. (1966). Nature, Lund. 209, 1140. 
BRECHER, G. & STOHLMAN, F., JR. (1962). In Erythropoiesis. (L. 0. Jacobson & M. Doyle, 
eds.) p. 216. New York: Grune & Stratton. 
CONTRERA, J. F. & GORDON, A. S. (1968). Ann. N. Y. Acad. Sci. 149, 114. 
CROSBY, W. H. & AKEROYD, J. H. (1952). Am. J. Med. 13, 273. 
CROWELL, J. W. & SMITH, E. E. (1967). J. appl. Physiol. 22, 501. 
ERSLEV, A. J. (1960). A. Rev. Med. 11, 315. 
GALL, D. A. & MENO, F. (1968). Proc. a. ConJ Engng Med. Biol. 10, 32. 
GARBY, L., SCHNEIDER, W., SUNDQUST, 0. & VUILLE, J. (1963). Aeta. physial. stand. 29, 
Suppl. 216. 
HARRIS, J. W. (1963). The Red Cell, p. 125. Cambridge, Mass.: Harvard University Press. 
JACOBXIN, L. O., GOLDWASSER, E. & GURNEY, C. W. (1959). The Kinetics of Cellular Pro- 
liferation. (F. Stohlman, ed.). New York: Grune & Stratton. 
JACOBSEN, L. O., GURNEY, C. W. 8~ GOLDWASSER, E. (1960). Adv. intern. Med. 10, 297. 
KEIGHLEY, G. (1962). In Erythrapoiesis. (L. 0. Jacobson & M. Doyle, eds.) p. 106. New 
York: Grune & Stratton. 
KIRK, J., ORR, J. S. & HOPE, C. S. (1968). Br. J. Haematol. 15, 35. 
KRETCHMAR, A. L. (1966). Science, N. Y. 152, 367. 
KURATOWSKA, Z., LEWARTOWSKI, B. & LIPINSKI, B. (1964). J. Lab. clin. Med. 64, 226. 
LAJTHA, L. G. & OLIVER, R. (1960). In Ciba Foundation Sytnposian~ on Haemopoiesis. 
(G. E. W. Wolstenholme & M. O’Connor, eds.) p. 289. London: Churchill. 
LENFANT, C., WAYS, P., AUCUT-~, C. & CRUZ, J. (1969). Resp. Physiol. 7, 7. 
MYLREA, K. C. (1968). Ph. D. Dissertation. Ann. Arbor, Michigan, University of 
Michigan. 
MYLREA, K. C. & ABBRECHT, P. H. (1970). Am. J. Physiol. 218, 1145. 
NATHAN, D. G., SCHUPAK, E., STOHLMAN, F., JR. 2% MERRILL, J. P. (1964). J. clin. Invest. 
43, 2158. 
NEUBERGER, A. & NIVEN, J. S. F. (1951). J. Physiol., Land. 112, 292. 
NEWWN, C. M. & GURNEY, C. W. (1965). Biophys. J. 5, 134. 
NOONEY, G. C. (1966). Biophys. J. 6, 601, 
ORLIC, D., GORDON, A. S. & RHODIN. J. A. R. (1968). Ann. N. Y. Acad. Sci. 149, 198. 
POLLYCOVE, M. & MORTIMER, R. (1961). J. clin. Invest. 40, 753. 
PRENTICE, T. C. & MIRAND, A. E. (1961). Proc. Sot. exp. Biol. Med. 106, 501. 
RAHN, H. & FENN, W. 0. (1955). A Graphical Analysis of Respiratory Gas Exchange. 
Washington, D.C. : The American Physiological Society. 
REISSMAN, K. R., DIEDERICH, D. A., ITO, K. & SCHMAUS. J. W. (1965). J. Lab. clin. Med. 
65, 967. 
SHARNEY, L., WASSERMAN, L. R.. SCHWARTZ, L. & TENDLER, D. (1963). Ann. N. Y. Acad. 
Sci. 108, 230. 
MODEL FOR CONTROL OF ERYTHROPOlESIS 297 
SIRI, W. E., VAN DYKE, D. C., WINCHELL, H. S., POLLYCOVE, M., PARKER, H. G. & 
CLEVELAND, A. S. (1966). J. appl. Physiol. 21, 73. 
STOHLMAN, F., JR. (1959). Ann. N. Y. Acad. Sci. 77, 7 10. 
STOHLMAN, F., JR., EBBE, S., MORSE, B., HOWARD, D. & DONOVAN, J. (1968). Ann. 
N. Y. Acad. Sci. 149, 156. 
STOHLMAN, F., JR. & HOWARD, D. (1962). In Erythropoiesis. (L. 0. Jacobson & M. Doyle, 
eds.) p. 120. New York: Grune & Stratton. 
VAN DYKE, D. C. & POLLYCOVE, M. (1962). In Evythropoiesis. (L. 0. Jacobson & M. Doyle, 
eds.) p. 340. New York: Grune & Stratton. 
VAN LIERE, E. J. & STICKNEY, J. C. (1963). Hypoxia, p. 37. Chicago: University of 
Chicago. 
ZANJANI, E. D., CONTRERA, J. F., GORWN, A. S., COOPER, G. W.. WONG, K. K. & KATZ. R. 
(1967). Proc. Sot. exp. Biol. Med. 125, 505. 
